"Why I Am Not Infected With HIV": Implications for Long-Term HIV Risk Reduction and HIV Vaccine Trials
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 16 (5) , 393-399
- https://doi.org/10.1097/00042560-199712150-00013
Abstract
To describe beliefs about remaining HIV-seronegative in injecting drug users in two high-seroprevalence cities, and to consider implications of these beliefs for ongoing risk reduction efforts and for HIV vaccine efficacy trials. Cross-sectional survey with open- and closed-ended questions. 58 HIV-seronegative injecting drug users participating in HIV vaccine preparation cohort studies in New York City, New York, U.S.A., and Bangkok, Thailand. Large majorities of subjects in Bangkok (90%) and in New York (89%) believed their "own efforts" to practice safer injection methods and safer sex were very important in avoiding HIV infection. More Bangkok subjects (30%) believed that they would "probably" become infected with HIV in the future than New York subjects (4%). Three percent of Bangkok subjects and 70% of New York subjects believed "having an immune system strong enough to avoid becoming infected with HIV despite exposure to the virus" was very important in avoiding HIV infection. This belief in New York subjects was associated with having previously engaged in high-risk behaviors (i.e., sharing injection equipment, unprotected sex, or both) with partners known to be HIV-seropositive. Risk reduction programming for high-HIV-seroprevalence populations and within HIV vaccine trials should address not only specific HIV risk behaviors, but also the complex belief systems about avoiding HIV infection that develop within such groups. The person's "own efforts/self-efficacy" appears to be central in the psychology of risk reduction. Members of some high-risk populations may overestimate greatly the frequency of any possible natural immunity to becoming infected with HIV. Prevention programs for these populations will need to address explicitly the probabilistic nature of HIV transmission.Keywords
This publication has 14 references indexed in Scilit:
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progressionNature Medicine, 1996
- HIV prevention in developed countriesThe Lancet, 1996
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.American Journal of Public Health, 1996
- Maintaining low HIV seroprevalence in populations of injecting drug usersPublished by American Medical Association (AMA) ,1995
- Risk Factors for Human Immunodeficiency Virus Seroconversion among Out-of-Treatment Drug Injectors in High and Low Seroprevalence CitiesAmerican Journal of Epidemiology, 1995
- Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method.American Journal of Public Health, 1994
- Opiate dependency among the subscribers of a New York area private insurance planJAMA, 1993
- The Next Problem: Maintenance of AIDS Risk Reduction among Intravenous Drug UsersInternational Journal of the Addictions, 1991
- Toward an Anthropology of Immunology: The Body as Nation StateMedical Anthropology Quarterly, 1990